Congenital myasthenic syndrome (CMS): pathway classification

Evidence-based neurology checklist on congenital myasthenic syndrome (cms): pathway classification: Presynaptic defects CHAT choline acetyl transferase mutations (CMS 6) Synaptotagmin 2: synaptic vesicle-associated calcium sensor (CMS 7) SNAP25B: synaptic vesicle exocytosis (CMS 18) VAChT:…

Presynaptic defects

  • CHAT choline acetyl transferase mutations (CMS 6)
  • Synaptotagmin 2: synaptic vesicle-associated calcium sensor (CMS 7)
  • SNAP25B: synaptic vesicle exocytosis (CMS 18)
  • VAChT: vesicular acetylcholine transporter SLC5A7 (CMS 20)
  • VAChT: vesicular acetylcholine transporter SLC18A3 (CMS 21)

Synaptic defects

Endplate development and maintenance defects

Postsynaptic (acetylcholine receptor) defects

Glycosylation pathway defects

Myasthenia associated with centronuclear myopathies

Other myasthenic syndromes

References

  1. Beeson D, Hantai D, Lochmuller H, Engel AG. 126th International Workshop: congenital myasthenic syndromes, 24-26 September 2004, Naarden, the Netherlands. Neuromuscul Disord 2005; 15:498-512.
  2. Spillane J, Beeson DJ, Kullmann DM. Myasthenia and related disorders of the neuromuscular junction. JNNP 2010; 81:850-857.
  3. Finlayson S, Beeson D, Palace J. Congenital myasthenic syndrome: an update. Pract Neurol 2013; 13:80-91.
  4. Engel AG, Shen XM, Selcen D, Sine SM. Congenital myasthenic syndromes: pathogenesis, diagnosis, and treatment. Lancet Neurol 2015; 14:461.
  5. McMacken G, Whittaker RG, Evangelista T, Abicht A, Dusl M, Lochmüller H. Congenital myasthenic syndrome with episodic apnoea: clinical, neurophysiological and genetic features in the long-term follow-up of 19 patients. J Neurol 2018; 265:194-203.
  6. And 16 more. Subscribe to see the full list

Related checklists

Loading...